Position in RLAY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,468,621
+$2,318,905 QoQ
Shares Held
238,836
+10.5% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 34%
None 66%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. RLAY ranks #43 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,468,621 | 238,836 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,149,716 | 216,052 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $207,904 | 24,575 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $128,281 | 24,575 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $125,826 | 36,366 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $89,171 | 34,035 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $666,726 | 161,827 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $232,882 | 32,893 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $217,337 | 33,334 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $249,423 | 30,051 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $413,392 | 37,547 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $1,136,493 | 135,136 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $963,665 | 76,725 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $1,682,838 | 102,176 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $1,526,509 | 102,176 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $2,213,779 | 98,962 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $481,931 | 28,772 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $796,736 | 26,620 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $761,208 | 24,787 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $722,699 | 22,921 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $838,679 | 22,921 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $686,041 | 19,845 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $581,673 | 13,996 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $435,142 | 10,217 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||